Ken Griffin Ainos, Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.57 - $1.05 $7,975 - $14,691
13,992 New
13,992 $8,000
Q4 2022

Feb 14, 2023
SELL
$0.6 - $1.15 $3,760 - $7,208
-6,268 Reduced 14.06%
38,318 $23,000
Q3 2022

Nov 14, 2022
BUY
$0.29 - $10.8 $12,929 - $481,528
44,586 New
44,586 $84,000

About Ainos, Inc.

AIMD Quotes by TradingView
  • Ticker AIMD
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,478,300
  • Market Cap $15.8M
  • Description
  • Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a per...
More about AIMD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email